Uganda

Uganda

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.76 (4.35 - 5.20) 2019 Modelled IHME
4.99 (4.58 - 5.43) 2018 Modelled IHME
5.22 (4.77 - 5.72) 2017 Modelled IHME
5.45 (4.97 - 5.95) 2016 Modelled IHME
5.68 (5.14 - 6.20) 2015 Modelled IHME
5.92 (5.35 - 6.47) 2014 Modelled IHME
6.16 (5.57 - 6.74) 2013 Modelled IHME
6.4 (5.79 - 7.05) 2012 Modelled IHME
6.66 (6.01 - 7.36) 2011 Modelled IHME
6.93 (6.23 - 7.69) 2010 Modelled IHME
7.22 (6.49 - 8.05) 2009 Modelled IHME
7.53 (6.73 - 8.38) 2008 Modelled IHME
7.85 (7 - 8.73) 2007 Modelled IHME
8.18 (7.25 - 9.11) 2006 Modelled IHME
8.5 (7.53 - 9.50) 2005 Modelled IHME
8.85 (7.86 - 9.88) 2004 Modelled IHME
9.23 (8.23 - 10.30) 2003 Modelled IHME
9.6 (8.58 - 10.74) 2002 Modelled IHME
9.92 (8.86 - 11.16) 2001 Modelled IHME
10.16 (9.03 - 11.46) 2000 Modelled IHME
10.35 (9.20 - 11.70) 1999 Modelled IHME
10.52 (9.33 - 11.90) 1998 Modelled IHME
10.66 (9.44 - 12.08) 1997 Modelled IHME
10.76 (9.49 - 12.20) 1996 Modelled IHME
10.8 (9.50 - 12.23) 1995 Modelled IHME
10.81 (9.56 - 12.26) 1994 Modelled IHME
10.82 (9.61 - 12.23) 1993 Modelled IHME
10.82 (9.60 - 12.21) 1992 Modelled IHME
10.82 (9.59 - 12.19) 1991 Modelled IHME
10.82 (9.54 - 12.20) 1990 Modelled IHME
4.1 (3.80 - 4.40) 2017 Survey/reported Uganda Population-based HIV Impact Assessment (UPHIA) 2016-2017, 2019
6.29 (5.09 - 7.75) 2015 Modelled WHO
5.5 (4.50 - 6) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.89 (0.68 - 1.13) 2019 Modelled IHME
0.95 (0.73 - 1.21) 2018 Modelled IHME
1.01 (0.78 - 1.29) 2017 Modelled IHME
1.07 (0.83 - 1.35) 2016 Modelled IHME
1.15 (0.89 - 1.45) 2015 Modelled IHME
1.25 (0.97 - 1.56) 2014 Modelled IHME
1.37 (1.07 - 1.70) 2013 Modelled IHME
1.5 (1.16 - 1.87) 2012 Modelled IHME
1.64 (1.27 - 2.04) 2011 Modelled IHME
1.77 (1.38 - 2.24) 2010 Modelled IHME
1.88 (1.46 - 2.34) 2009 Modelled IHME
1.97 (1.54 - 2.45) 2008 Modelled IHME
2.07 (1.62 - 2.57) 2007 Modelled IHME
2.21 (1.72 - 2.75) 2006 Modelled IHME
2.39 (1.85 - 3) 2005 Modelled IHME
3.04 (2.38 - 3.82) 2004 Modelled IHME
4.28 (3.37 - 5.38) 2003 Modelled IHME
5.72 (4.50 - 7.24) 2002 Modelled IHME
6.94 (5.48 - 8.85) 2001 Modelled IHME
7.57 (5.91 - 9.64) 2000 Modelled IHME
7.76 (6.02 - 9.76) 1999 Modelled IHME
7.91 (6.12 - 9.88) 1998 Modelled IHME
8.02 (6.17 - 9.99) 1997 Modelled IHME
8.09 (6.24 - 10.04) 1996 Modelled IHME
8.12 (6.27 - 10.15) 1995 Modelled IHME
8.13 (6.28 - 10.18) 1994 Modelled IHME
8.13 (6.32 - 10.15) 1993 Modelled IHME
8.12 (6.37 - 10.12) 1992 Modelled IHME
8.1 (6.38 - 10.14) 1991 Modelled IHME
8.07 (6.37 - 10.18) 1990 Modelled IHME
3.16 (2.28 - 4.29) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,873,710 (1,651,470 - 2,112,040) 1990 Modelled IHME
1,933,180 (1,713,890 - 2,177,740) 1991 Modelled IHME
1,996,410 (1,771,110 - 2,252,790) 1992 Modelled IHME
2,063,240 (1,833,640 - 2,332,980) 1993 Modelled IHME
2,133,500 (1,887,200 - 2,419,030) 1994 Modelled IHME
2,207,040 (1,939,850 - 2,499,180) 1995 Modelled IHME
2,276,300 (2,007,120 - 2,580,220) 1996 Modelled IHME
2,334,970 (2,067,010 - 2,645,620) 1997 Modelled IHME
2,384,820 (2,116,390 - 2,697,460) 1998 Modelled IHME
2,427,900 (2,158,430 - 2,745,260) 1999 Modelled IHME
2,466,710 (2,193,250 - 2,782,690) 2000 Modelled IHME
2,489,710 (2,222,630 - 2,801,300) 2001 Modelled IHME
2,487,650 (2,222,220 - 2,783,450) 2002 Modelled IHME
2,467,640 (2,199,860 - 2,753,980) 2003 Modelled IHME
2,438,910 (2,165,390 - 2,722,900) 2004 Modelled IHME
2,412,160 (2,134,830 - 2,695,300) 2005 Modelled IHME
2,387,110 (2,117,540 - 2,659,800) 2006 Modelled IHME
2,356,770 (2,101,370 - 2,620,200) 2007 Modelled IHME
2,323,130 (2,077,120 - 2,586,180) 2008 Modelled IHME
2,288,570 (2,058,340 - 2,551,870) 2009 Modelled IHME
2,255,720 (2,029,890 - 2,504,600) 2010 Modelled IHME
2,225,740 (2,010,110 - 2,459,520) 2011 Modelled IHME
2,197,280 (1,986,910 - 2,419,720) 2012 Modelled IHME
2,169,160 (1,963,630 - 2,373,510) 2013 Modelled IHME
2,139,950 (1,935,970 - 2,339,840) 2014 Modelled IHME
2,108,100 (1,907,880 - 2,299,290) 2015 Modelled IHME
2,074,480 (1,891,950 - 2,265,090) 2016 Modelled IHME
2,038,780 (1,862,180 - 2,232,640) 2017 Modelled IHME
1,999,070 (1,836,180 - 2,174,930) 2018 Modelled IHME
1,956,320 (1,787,590 - 2,139,520) 2019 Modelled IHME
2,291,000 (1,856,000 - 2,473,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.93 (2 - 4.10) 2019 Modelled IHME
2.94 (2.03 - 4.08) 2018 Modelled IHME
2.92 (2.05 - 4.03) 2017 Modelled IHME
2.96 (2.06 - 4.11) 2016 Modelled IHME
2.99 (2.10 - 4.16) 2015 Modelled IHME
3.13 (2.20 - 4.29) 2014 Modelled IHME
3.33 (2.32 - 4.52) 2013 Modelled IHME
3.5 (2.45 - 4.77) 2012 Modelled IHME
3.65 (2.57 - 4.93) 2011 Modelled IHME
3.73 (2.63 - 4.97) 2010 Modelled IHME
3.77 (2.69 - 5) 2009 Modelled IHME
3.84 (2.71 - 5.11) 2008 Modelled IHME
3.99 (2.84 - 5.29) 2007 Modelled IHME
4.09 (2.86 - 5.46) 2006 Modelled IHME
4.19 (2.92 - 5.62) 2005 Modelled IHME
4.3 (2.96 - 5.79) 2004 Modelled IHME
4.41 (3.05 - 5.95) 2003 Modelled IHME
4.56 (3.17 - 6.11) 2002 Modelled IHME
4.74 (3.33 - 6.43) 2001 Modelled IHME
4.81 (3.39 - 6.57) 2000 Modelled IHME
4.84 (3.42 - 6.57) 1999 Modelled IHME
4.89 (3.46 - 6.66) 1998 Modelled IHME
4.88 (3.48 - 6.63) 1997 Modelled IHME
4.92 (3.49 - 6.75) 1996 Modelled IHME
4.89 (3.49 - 6.75) 1995 Modelled IHME
4.89 (3.48 - 6.78) 1994 Modelled IHME
4.86 (3.46 - 6.85) 1993 Modelled IHME
4.83 (3.38 - 6.87) 1992 Modelled IHME
4.87 (3.48 - 7) 1991 Modelled IHME
4.77 (3.31 - 6.86) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,206 (821 - 1,687) 2019 Modelled IHME
1,177 (812 - 1,635) 2018 Modelled IHME
1,142 (800 - 1,573) 2017 Modelled IHME
1,127 (786 - 1,564) 2016 Modelled IHME
1,110 (781 - 1,545) 2015 Modelled IHME
1,133 (796 - 1,551) 2014 Modelled IHME
1,173 (819 - 1,592) 2013 Modelled IHME
1,202 (840 - 1,639) 2012 Modelled IHME
1,221 (860 - 1,647) 2011 Modelled IHME
1,216 (856 - 1,618) 2010 Modelled IHME
1,196 (853 - 1,584) 2009 Modelled IHME
1,185 (837 - 1,579) 2008 Modelled IHME
1,198 (854 - 1,587) 2007 Modelled IHME
1,195 (834 - 1,594) 2006 Modelled IHME
1,190 (827 - 1,593) 2005 Modelled IHME
1,185 (814 - 1,595) 2004 Modelled IHME
1,179 (816 - 1,590) 2003 Modelled IHME
1,183 (820 - 1,584) 2002 Modelled IHME
1,190 (835 - 1,613) 2001 Modelled IHME
1,169 (823 - 1,595) 2000 Modelled IHME
1,136 (802 - 1,542) 1999 Modelled IHME
1,109 (785 - 1,509) 1998 Modelled IHME
1,069 (763 - 1,452) 1997 Modelled IHME
1,040 (739 - 1,428) 1996 Modelled IHME
1,000 (713 - 1,378) 1995 Modelled IHME
965 (687 - 1,338) 1994 Modelled IHME
927 (659 - 1,306) 1993 Modelled IHME
892 (624 - 1,267) 1992 Modelled IHME
870 (621 - 1,251) 1991 Modelled IHME
825 (573 - 1,189) 1990 Modelled IHME
2,532 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
29 (22 - 37) 2019 Modelled IHME
29 (22 - 37) 2018 Modelled IHME
29 (22 - 37) 2017 Modelled IHME
29 (22 - 37) 2016 Modelled IHME
29 (22 - 37) 2015 Modelled IHME
29 (22 - 37) 2014 Modelled IHME
29 (22 - 37) 2013 Modelled IHME
30 (23 - 37) 2012 Modelled IHME
30 (23 - 38) 2011 Modelled IHME
30 (23 - 38) 2010 Modelled IHME
30 (23 - 38) 2009 Modelled IHME
30 (23 - 38) 2008 Modelled IHME
30 (23 - 38) 2007 Modelled IHME
30 (23 - 38) 2006 Modelled IHME
30 (23 - 38) 2005 Modelled IHME
31 (24 - 39) 2004 Modelled IHME
31 (24 - 39) 2003 Modelled IHME
31 (24 - 39) 2002 Modelled IHME
31 (24 - 39) 2001 Modelled IHME
31 (24 - 40) 2000 Modelled IHME
31 (24 - 40) 1999 Modelled IHME
31 (24 - 40) 1998 Modelled IHME
31 (24 - 40) 1997 Modelled IHME
31 (25 - 40) 1996 Modelled IHME
31 (24 - 40) 1995 Modelled IHME
31 (24 - 40) 1994 Modelled IHME
31 (24 - 40) 1993 Modelled IHME
31 (24 - 40) 1992 Modelled IHME
31 (23 - 40) 1991 Modelled IHME
30 (23 - 39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
93 2018 Survey/reported WHO/UNICEF
94 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
89 2015 Survey/reported WHO/UNICEF
85 2014 Survey/reported WHO/UNICEF
84 2013 Survey/reported WHO/UNICEF
83 2012 Survey/reported WHO/UNICEF
82 2011 Survey/reported WHO/UNICEF
80 2010 Survey/reported WHO/UNICEF
79 2009 Survey/reported WHO/UNICEF
71 2008 Survey/reported WHO/UNICEF
73 2007 Survey/reported WHO/UNICEF
64 2006 Survey/reported WHO/UNICEF
64 2005 Survey/reported WHO/UNICEF
62 2004 Survey/reported WHO/UNICEF
44 2003 Survey/reported WHO/UNICEF
29 2002 Survey/reported WHO/UNICEF
93 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
11 2016 Survey/reported Larney S et al, 2017
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.6 (1.27 - 2.01) 2019 Modelled IHME
1.61 (1.28 - 1.99) 2018 Modelled IHME
1.61 (1.28 - 2.01) 2017 Modelled IHME
1.61 (1.28 - 2.01) 2016 Modelled IHME
1.61 (1.28 - 2.01) 2015 Modelled IHME
1.64 (1.32 - 2.03) 2014 Modelled IHME
1.72 (1.40 - 2.11) 2013 Modelled IHME
1.83 (1.50 - 2.22) 2012 Modelled IHME
1.93 (1.58 - 2.31) 2011 Modelled IHME
2 (1.63 - 2.39) 2010 Modelled IHME
2.04 (1.68 - 2.45) 2009 Modelled IHME
2.09 (1.71 - 2.50) 2008 Modelled IHME
2.13 (1.74 - 2.54) 2007 Modelled IHME
2.15 (1.76 - 2.57) 2006 Modelled IHME
2.16 (1.78 - 2.59) 2005 Modelled IHME
2.14 (1.75 - 2.56) 2004 Modelled IHME
2.1 (1.71 - 2.53) 2003 Modelled IHME
2.05 (1.67 - 2.51) 2002 Modelled IHME
2.01 (1.61 - 2.49) 2001 Modelled IHME
1.99 (1.58 - 2.50) 2000 Modelled IHME
2 (1.59 - 2.51) 1999 Modelled IHME
2.02 (1.62 - 2.54) 1998 Modelled IHME
2.05 (1.65 - 2.58) 1997 Modelled IHME
2.08 (1.67 - 2.63) 1996 Modelled IHME
2.1 (1.68 - 2.66) 1995 Modelled IHME
2.11 (1.69 - 2.66) 1994 Modelled IHME
2.12 (1.71 - 2.67) 1993 Modelled IHME
2.14 (1.72 - 2.68) 1992 Modelled IHME
2.15 (1.72 - 2.69) 1991 Modelled IHME
2.15 (1.72 - 2.71) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
372,840 (297,164 - 468,802) 1990 Modelled IHME
383,197 (306,765 - 480,871) 1991 Modelled IHME
393,934 (316,872 - 495,106) 1992 Modelled IHME
405,031 (325,930 - 509,491) 1993 Modelled IHME
416,463 (334,316 - 525,522) 1994 Modelled IHME
428,221 (343,139 - 543,273) 1995 Modelled IHME
439,143 (353,697 - 555,317) 1996 Modelled IHME
448,838 (360,734 - 565,218) 1997 Modelled IHME
458,530 (366,830 - 576,989) 1998 Modelled IHME
469,623 (374,230 - 588,121) 1999 Modelled IHME
483,724 (384,294 - 606,697) 2000 Modelled IHME
504,423 (404,162 - 625,442) 2001 Modelled IHME
531,815 (431,538 - 650,934) 2002 Modelled IHME
561,998 (458,287 - 677,466) 2003 Modelled IHME
590,713 (482,447 - 705,287) 2004 Modelled IHME
613,244 (503,602 - 734,262) 2005 Modelled IHME
628,223 (514,589 - 751,537) 2006 Modelled IHME
638,251 (522,911 - 762,822) 2007 Modelled IHME
644,363 (528,400 - 770,860) 2008 Modelled IHME
647,800 (531,519 - 777,187) 2009 Modelled IHME
649,952 (532,511 - 777,038) 2010 Modelled IHME
643,863 (528,115 - 771,078) 2011 Modelled IHME
626,679 (513,550 - 760,377) 2012 Modelled IHME
606,720 (493,425 - 742,165) 2013 Modelled IHME
593,190 (478,630 - 734,449) 2014 Modelled IHME
596,279 (475,162 - 746,291) 2015 Modelled IHME
612,278 (489,020 - 763,970) 2016 Modelled IHME
628,752 (500,166 - 785,503) 2017 Modelled IHME
643,826 (512,925 - 799,312) 2018 Modelled IHME
657,784 (523,842 - 825,569) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.85 (3.38 - 6.53) 2019 Modelled IHME
4.87 (3.36 - 6.52) 2018 Modelled IHME
4.85 (3.36 - 6.59) 2017 Modelled IHME
4.84 (3.38 - 6.48) 2016 Modelled IHME
4.8 (3.44 - 6.42) 2015 Modelled IHME
4.79 (3.42 - 6.37) 2014 Modelled IHME
4.68 (3.34 - 6.22) 2013 Modelled IHME
4.53 (3.27 - 5.97) 2012 Modelled IHME
4.44 (3.21 - 5.89) 2011 Modelled IHME
4.43 (3.19 - 5.85) 2010 Modelled IHME
4.49 (3.27 - 5.97) 2009 Modelled IHME
4.6 (3.39 - 6.05) 2008 Modelled IHME
4.79 (3.53 - 6.28) 2007 Modelled IHME
4.95 (3.63 - 6.48) 2006 Modelled IHME
5.1 (3.73 - 6.65) 2005 Modelled IHME
5.23 (3.78 - 6.93) 2004 Modelled IHME
5.35 (3.88 - 7.11) 2003 Modelled IHME
5.52 (4.02 - 7.37) 2002 Modelled IHME
5.69 (4.16 - 7.59) 2001 Modelled IHME
5.79 (4.19 - 7.70) 2000 Modelled IHME
5.86 (4.27 - 7.84) 1999 Modelled IHME
5.95 (4.32 - 8.03) 1998 Modelled IHME
5.97 (4.33 - 8.13) 1997 Modelled IHME
6.03 (4.35 - 8.29) 1996 Modelled IHME
6.03 (4.35 - 8.14) 1995 Modelled IHME
6.05 (4.33 - 8.28) 1994 Modelled IHME
6.03 (4.34 - 8.13) 1993 Modelled IHME
6.02 (4.29 - 8.25) 1992 Modelled IHME
6.06 (4.31 - 8.41) 1991 Modelled IHME
5.95 (4.21 - 8.37) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,995 (1,390 - 2,685) 2019 Modelled IHME
1,953 (1,345 - 2,614) 2018 Modelled IHME
1,894 (1,311 - 2,574) 2017 Modelled IHME
1,842 (1,288 - 2,469) 2016 Modelled IHME
1,780 (1,275 - 2,384) 2015 Modelled IHME
1,731 (1,238 - 2,304) 2014 Modelled IHME
1,650 (1,178 - 2,193) 2013 Modelled IHME
1,555 (1,123 - 2,049) 2012 Modelled IHME
1,483 (1,075 - 1,969) 2011 Modelled IHME
1,442 (1,040 - 1,907) 2010 Modelled IHME
1,425 (1,037 - 1,892) 2009 Modelled IHME
1,418 (1,046 - 1,869) 2008 Modelled IHME
1,439 (1,059 - 1,885) 2007 Modelled IHME
1,445 (1,060 - 1,892) 2006 Modelled IHME
1,447 (1,057 - 1,886) 2005 Modelled IHME
1,442 (1,041 - 1,908) 2004 Modelled IHME
1,431 (1,038 - 1,902) 2003 Modelled IHME
1,429 (1,041 - 1,911) 2002 Modelled IHME
1,429 (1,043 - 1,905) 2001 Modelled IHME
1,407 (1,017 - 1,870) 2000 Modelled IHME
1,375 (1,001 - 1,840) 1999 Modelled IHME
1,349 (980 - 1,820) 1998 Modelled IHME
1,308 (949 - 1,780) 1997 Modelled IHME
1,276 (920 - 1,752) 1996 Modelled IHME
1,233 (888 - 1,663) 1995 Modelled IHME
1,194 (854 - 1,634) 1994 Modelled IHME
1,151 (828 - 1,551) 1993 Modelled IHME
1,110 (791 - 1,523) 1992 Modelled IHME
1,083 (769 - 1,503) 1991 Modelled IHME
1,030 (729 - 1,450) 1990 Modelled IHME
1,439 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
18 (12 - 24) 2019 Modelled IHME
18 (13 - 24) 2018 Modelled IHME
18 (13 - 24) 2017 Modelled IHME
18 (12 - 24) 2016 Modelled IHME
18 (12 - 24) 2015 Modelled IHME
17 (12 - 23) 2014 Modelled IHME
17 (12 - 23) 2013 Modelled IHME
18 (12 - 23) 2012 Modelled IHME
18 (12 - 23) 2011 Modelled IHME
18 (12 - 23) 2010 Modelled IHME
18 (12 - 24) 2009 Modelled IHME
18 (12 - 24) 2008 Modelled IHME
18 (12 - 24) 2007 Modelled IHME
18 (12 - 24) 2006 Modelled IHME
18 (12 - 24) 2005 Modelled IHME
18 (12 - 24) 2004 Modelled IHME
18 (12 - 24) 2003 Modelled IHME
18 (12 - 24) 2002 Modelled IHME
17 (12 - 24) 2001 Modelled IHME
17 (12 - 24) 2000 Modelled IHME
17 (12 - 24) 1999 Modelled IHME
17 (12 - 24) 1998 Modelled IHME
17 (12 - 24) 1997 Modelled IHME
17 (12 - 24) 1996 Modelled IHME
17 (12 - 24) 1995 Modelled IHME
17 (12 - 24) 1994 Modelled IHME
17 (12 - 24) 1993 Modelled IHME
17 (12 - 24) 1992 Modelled IHME
17 (12 - 24) 1991 Modelled IHME
17 (12 - 24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
11 2016 Survey/reported Larney S et al, 2017
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
1,206
2019
(821 - 1,687)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,995
2019
(1,390 - 2,685)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines